Kerafast

Kerafast

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7.5M

Overview

Kerafast has established itself as a critical facilitator in the life sciences research supply chain by connecting reagent providers (primarily academic labs) with procurers (research scientists). The company's platform streamlines the legal and logistical complexities of material transfer, enabling the commercialization of reagents that would otherwise remain siloed within individual institutions. By aggregating a vast catalog of unique research tools, Kerafast addresses a key bottleneck in biomedical research, serving a global customer base that includes universities, government agencies, and biopharma companies. Its business model is based on revenue-sharing with the originating labs and institutions.

AntibodiesBiologics

Technology Platform

Online marketplace and service platform for sourcing, licensing, and distributing unique biological research reagents from academic labs globally.

Funding History

3
Total raised:$7.5M
Series B$5M
Series A$2M
Seed$500K

Opportunities

The growing emphasis on open science and reproducibility creates a larger market for accessible, well-documented research tools.
Expanding its network of prestigious institution partners and entering into exclusive distribution agreements can solidify its market position.
Leveraging data from search and purchase trends could allow Kerafast to identify and proactively source reagents in emerging, high-demand research fields.

Risk Factors

Dependence on academic labs for supply introduces volatility, as contributor incentives and institutional policies can change.
Operating as a distributor rather than a manufacturer limits quality control and exposes the company to reputational risk from reagent failures.
Intense competition from large reagent distributors and niche platforms threatens market share and margins.

Competitive Landscape

Kerafast competes in a fragmented segment of the life science tools market. Primary competitors include large, diversified distributors (e.g., Thermo Fisher Scientific, Merck Millipore) that also source some academic reagents, and specialized non-profit repositories like Addgene (for plasmids). Its key differentiator is a focused platform and service model dedicated entirely to the legal and logistical complexities of transferring unique materials from academia.